Arie Mayer
Director/Board Member chez ORAMED PHARMACEUTICALS INC.
Fortune : 280 711 $ au 31/03/2024
Profil
Arie Mayer is currently the Chairman & Managing Director at Sigma-Aldrich Israel Ltd.
since 2010 and an Independent Director at Oramed Pharmaceuticals, Inc. since 2019.
He holds a doctorate degree from Technion-Israel Institute of Technology and an undergraduate degree from The Hebrew University of Jerusalem.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/03/2024 | 96 134 ( 0,24% ) | 280 711 $ | 31/03/2024 |
Postes actifs de Arie Mayer
| Sociétés | Poste | Début |
|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Director/Board Member | 05/12/2019 |
Sigma-Aldrich Israel Ltd.
 Sigma-Aldrich Israel Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Sigma-Aldrich Israel Ltd. is an Israeli pharmaceutical company that manufactures pharmaceutical products. The private company is based in Rehovot, Israel. Arie Mayer has been the CEO of the company since 1995. | Chief Executive Officer | 01/01/2010 |
Formation de Arie Mayer
| Technion-Israel Institute of Technology | Doctorate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORAMED PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sigma-Aldrich Israel Ltd.
Sigma-Aldrich Israel Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Sigma-Aldrich Israel Ltd. is an Israeli pharmaceutical company that manufactures pharmaceutical products. The private company is based in Rehovot, Israel. Arie Mayer has been the CEO of the company since 1995. | Health Technology |
